January 13th 2021, 8:00pm
Direct access of primary care physicians to dermatologists via asynchronous teledermatology improves a health system’s ability to increase patient access to dermatologic care.
January 13th 2021, 5:00pm
The telehealth policy changes enacted for short-term control of the coronavirus disease 2019 (COVID-19) pandemic present an opportunity to address the fundamental gap in health care underutilization.
January 8th 2021, 2:00pm
TeleConnect introduces the concept of connecting primary care physicians and specialists by leveraging technology. Improving communication in a health care system betters patient care.
January 7th 2021, 2:32pm
With a rapid shift to telehealth during the coronavirus disease 2019 (COVID-19) pandemic, clinicians, health care organizations, and policy makers must consider and address patients’ evolving needs, concerns, and expectations.
January 5th 2021, 5:13pm
In an effort to detect sea fan neovascularization from ultra-widefield color fundus photographs from patients with sickle cell hemoglobinopathy, researchers developed an automated system with high sensitivity and specificity, which holds potential to improve screening for vision-threatening proliferative sickle cell retinopathy.
December 24th 2020, 6:00pm
Recent major investments signal growth in an emerging therapeutic sector.
December 18th 2020, 3:00pm
Texas Oncology physicians discuss utilization of telemedicine, evaluating trends, barriers, and opportunities in care delivery during the coronavirus disease 2019 pandemic.
December 14th 2020, 5:00pm
Stark realities exposed by the pandemic have led some to advocate for redirecting resources to have the most impact on vulnerable populations.
December 10th 2020, 4:15pm
What people believe about health and public health, although challenged before the coronavirus disease 2019 (COVID-19) pandemic, is even more crucial now as vaccine distribution efforts could soon begin.
December 9th 2020, 8:04pm
Researchers found the application of FOLFOXai, an artificial intelligence (AI)–based predictor of response to FOLFOX chemotherapy in metastatic colorectal cancer (mCRC), may lead to improved treatment outcomes for some patients with mCRC and other cancers.
